ACTIVE

OMEGA PHARMA TRADING

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-31 k €+97,9 %over 1 year
Revenue538,6 k €-86,8 %over 1 year
Equity2,7 M €-11,9 %over 1 year
Workforce1,0 ETP-60,0 %over 1 year

Identity

Source · BCE/KBO

OMEGA PHARMA TRADING is a Public limited company incorporated in 1977. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 1,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0417.092.080
Incorporation
07/04/1977
Legal form
Public limited company
Registered office
Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map
Contributed capital
198 315,00 €
Latest accounts
31/12/2025
Average workforce
1,0 ETP
Joint committees (3)
  • 116
  • 207
  • 218
Signals
Solid equityLow riskGood liquidityHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 18 financial years

20252023202220212020
Income statement
Revenue538,6 k €4,1 M €4,5 M €10,6 M €8,8 M €
EBITDA-310 k €-1,5 M €1,6 M €3,2 M €798,3 k €
Operating result-49,1 k €-1,5 M €1,6 M €3,2 M €654,1 k €
Net result-31 k €-1,5 M €937,5 k €2,3 M €1,3 M €
Balance sheet
Equity2,7 M €3,1 M €4,5 M €3,6 M €1,3 M €
Total assets2,8 M €4,9 M €5,8 M €5,2 M €3,9 M €
Cash–1,3 k €–––
Debts101,1 k €1,8 M €1,2 M €1,6 M €2,7 M €
Other
Workforce1,0 ETP2,5 ETP2,4 ETP1,9 ETP1,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 42 ended

Active mandates

Jonas Dhaenens

Director · since 22 mai 2026 · until 13 mai 2032

Active
Sonia Hollies

Managing director · since 29 août 2024 · until 09 mai 2030

Active
Anja van Winsberghe

Director · since 27 janvier 2023 · until 22 mai 2026

Active
Magali Verbraeken

Director · since 27 janvier 2023 · until 27 mai 2029

Active

Ended mandates

Mira De Maeyer

Director · since 01 janvier 2024 · until 31 décembre 2029

Ended
Anja van Winsberghe

Director · since 27 janvier 2023 · until 10 mai 2029

Ended
Magali Verbraecken

Director · since 27 janvier 2023 · until 10 mai 2029

Ended
Magali Verbraeken

Director · since 27 janvier 2023 · until 10 mai 2029

Ended

Other companies at this address

Gaston Crommenlaan 6 9050 Gent
CompanyCBE no.
BRAVX● Active
0834.939.871
LIGHTHOUSE INTELLIGENCE● Active
0676.420.293
Oce-Bio● Active
0442.861.022
omega pharma group● Active
0837.048.632
OMEGA PHARMA INNOVATION & DEVELOPMENT● Active
0884.084.724
OMEGA PHARMA INTERNATIONAL● Active
0807.596.363
Perrigo Belgium● Active
0417.132.860
Perrigo Capital● Active
0430.784.027
Perrigo Europe Invest● Active
0439.658.834
Perrigo Holding● Active
0431.676.229
TM BRAVO4 CIVIEL● Active
0787.232.501
TM BRAVO-4 KOEPEL-EPC● Active
1008.974.796
TM Goedingebrug● Active
1039.143.281
TM Nieuwe Waasmunsterbrug over Durme● Active
1035.016.328

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date06/07/202618/06/202522/05/202431/05/202316/06/202214/06/2021
General meeting29/06/202620/05/202513/05/202411/05/202312/05/202217/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202529/06/202606/07/2026DutchPDF
Full model31/12/202420/05/202518/06/2025DutchPDF
Full model31/12/202313/05/202422/05/2024DutchPDF
Full model31/12/202211/05/202331/05/2023DutchPDF
Full model31/12/202112/05/202216/06/2022DutchPDF
Full model31/12/202017/05/202114/06/2021DutchPDF
Full model31/12/201914/05/202012/06/2020DutchPDF
Full model31/12/201809/05/201924/05/2019DutchPDF
Full model31/12/201730/05/201829/06/2018DutchPDF
Full model31/12/201620/06/201723/06/2017DutchPDF
Full model31/12/201530/06/201608/07/2016DutchPDF
Full model31/12/201408/07/201510/07/2015DutchPDF
Full model31/12/201318/06/201401/07/2014DutchPDF
Full model31/12/201229/05/201317/06/2013DutchPDF
Full model31/12/201130/05/201213/06/2012DutchPDF
Full model31/12/201025/05/201114/06/2011DutchPDF
Full model31/12/200923/06/201013/07/2010DutchPDF
Full model31/12/200824/06/200913/07/2009DutchPDF
Full model31/12/200728/05/200809/06/2008DutchPDF
Full model31/12/200625/06/200712/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 42 ended

Active mandates

Jonas Dhaenens

Director · since 22 mai 2026 · until 13 mai 2032

Active
Sonia Hollies

Managing director · since 29 août 2024 · until 09 mai 2030

Active
Anja van Winsberghe

Director · since 27 janvier 2023 · until 22 mai 2026

Active
Magali Verbraeken

Director · since 27 janvier 2023 · until 27 mai 2029

Active

Ended mandates

Mira De Maeyer

Director · since 01 janvier 2024 · until 31 décembre 2029

Ended
Anja van Winsberghe

Director · since 27 janvier 2023 · until 10 mai 2029

Ended
Magali Verbraecken

Director · since 27 janvier 2023 · until 10 mai 2029

Ended
Magali Verbraeken

Director · since 27 janvier 2023 · until 10 mai 2029

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/06/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office15/03/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates07/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other25/07/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN
    PDF
  • Mandates09/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-31 k €↑
  2. 2023
    Annual accounts 2023-1,5 M €↓
  3. 2022
    Annual accounts 2022937,5 k €↓
  4. 2021
    Annual accounts 20212,3 M €↑
  5. 2020
    Annual accounts 20201,3 M €↑
  6. 2019
    Annual accounts 2019-776,6 k €↓
  7. 2018
    Annual accounts 2018923,6 k €↑
  8. 2017
    Annual accounts 2017-511,5 k €↓
  9. 2016
    Annual accounts 2016-187,9 k €↓
  10. 2015
    Annual accounts 2015148,8 k €↑
  11. 2014
    Annual accounts 2014123,7 k €↑
  12. 2013
    Annual accounts 201326,3 k €↓
  13. 2012
    Annual accounts 2012414,8 k €↑
  14. 2012
    Name changeOmega Pharma Trading
  15. 2011
    Annual accounts 2011301,7 k €↑
  16. 2010
    Annual accounts 2010-147,3 k €↑
  17. 2009
    Annual accounts 2009-267,2 k €↓
  18. 2009
    Name changeJRO PHARMA
  19. 2008
    Annual accounts 2008265,1 k €↑
  20. 2007
    Annual accounts 2007165,2 k €
  21. 2007
    Name changeHomeopatisch Laboratorium SIMILIA
  22. 07/04/1977
    IncorporationPublic limited company